ArticleOncoTargets and therapy2016

Progesterone receptor loss identifies hormone receptor-positive and HER2-negative breast cancer subgroups at higher risk of relapse: a retrospective cohort study.

Jia-Yuan Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.